One of the questions ocular health practitioners ask about Ultra-widefield retinal imaging (UWF™) is about optomap acceptance rates. Will patients really be interested in a new and possibly unfamiliar diagnostic procedure that’s not covered by insurance? It’s the right question, because even a proven technique such as UWF is of limited clinical value if patients are reluctant to authorize the procedure.
Many doctors using UWF imaging report high optomap acceptance rates, leading to improved patient experience, better patient flow, and faster recovery of initial system costs. They’ve accomplished this by engaging their patients on a number of levels.
Explaining the Benefits
One common practice among doctors reporting high acceptance rates is that they take the time to explain to their patients the real medical benefits from incorporating an optomap into their annual examination. While comfort and convenience are also patient considerations, having an engaged and properly trained staff that can explain the medical benefits before, during, and after the exam is more impactful. As one doctor said:
“Explaining the tests you are performing, including high-level testing like optomap, that come with an out-of-pocket expense, need not add significant time to pre-testing. For that small amount of time and effort, …![]()